Causal effect of breast cancer on endometrial cancer risk: A two-sample Mendelian randomization study

IF 2.1 4区 医学 Q2 OBSTETRICS & GYNECOLOGY European journal of obstetrics, gynecology, and reproductive biology Pub Date : 2024-11-10 DOI:10.1016/j.ejogrb.2024.11.013
Meng Wang , Lan Li , Jing Li , Yongwei Li , Zhuoli Wang , Yuan Guo , Guochao Mao
{"title":"Causal effect of breast cancer on endometrial cancer risk: A two-sample Mendelian randomization study","authors":"Meng Wang ,&nbsp;Lan Li ,&nbsp;Jing Li ,&nbsp;Yongwei Li ,&nbsp;Zhuoli Wang ,&nbsp;Yuan Guo ,&nbsp;Guochao Mao","doi":"10.1016/j.ejogrb.2024.11.013","DOIUrl":null,"url":null,"abstract":"<div><h3>Background</h3><div>Observational studies have indicated a higher incidence of endometrial cancer in individuals with breast cancer. However, to date, there is a dearth of Mendelian randomization (MR) studies that explore the causal relationship between breast cancer and the risk of endometrial cancer.</div></div><div><h3>Material and methods</h3><div>We conducted MR to investigate the causal relationship between breast cancer and endometrial cancer risk in European populations.</div></div><div><h3>Results</h3><div>A total of 112 valid instrumental variables (IVs) were included in the analysis. Our research has revealed a compelling causal association between genetic predisposition for breast cancer and an augmented likelihood of developing endometrial cancer (Inverse variance weighted (IVW) method, odds ratio (OR) = 1.105, 95 % confidence interval (CI): 1.025 to 1.181, <em>p</em> = 0.003; Weighted median method, OR = 1.109, 95 % CI: 1.020 to 1.205, <em>p</em> = 0.015; Weighted mode method, OR = 1.101, 95 % CI: 1.013 to 1.195, <em>p</em> = 0.025).</div></div><div><h3>Conclusion</h3><div>To our knowledge, this study is the first to report a causal association between breast cancer and endometrial cancer risk. Robust results were obtained through rigorous testing for heterogeneity and pleiotropy. Our findings indicate a causal effect of breast cancer on the risk of endometrial cancer.</div></div>","PeriodicalId":11975,"journal":{"name":"European journal of obstetrics, gynecology, and reproductive biology","volume":"304 ","pages":"Pages 16-22"},"PeriodicalIF":2.1000,"publicationDate":"2024-11-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"European journal of obstetrics, gynecology, and reproductive biology","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0301211524006195","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"OBSTETRICS & GYNECOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Background

Observational studies have indicated a higher incidence of endometrial cancer in individuals with breast cancer. However, to date, there is a dearth of Mendelian randomization (MR) studies that explore the causal relationship between breast cancer and the risk of endometrial cancer.

Material and methods

We conducted MR to investigate the causal relationship between breast cancer and endometrial cancer risk in European populations.

Results

A total of 112 valid instrumental variables (IVs) were included in the analysis. Our research has revealed a compelling causal association between genetic predisposition for breast cancer and an augmented likelihood of developing endometrial cancer (Inverse variance weighted (IVW) method, odds ratio (OR) = 1.105, 95 % confidence interval (CI): 1.025 to 1.181, p = 0.003; Weighted median method, OR = 1.109, 95 % CI: 1.020 to 1.205, p = 0.015; Weighted mode method, OR = 1.101, 95 % CI: 1.013 to 1.195, p = 0.025).

Conclusion

To our knowledge, this study is the first to report a causal association between breast cancer and endometrial cancer risk. Robust results were obtained through rigorous testing for heterogeneity and pleiotropy. Our findings indicate a causal effect of breast cancer on the risk of endometrial cancer.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
乳腺癌对子宫内膜癌风险的因果效应:双样本孟德尔随机研究。
背景:观察性研究表明,乳腺癌患者的子宫内膜癌发病率较高。然而,迄今为止,探讨乳腺癌与子宫内膜癌风险之间因果关系的孟德尔随机化(MR)研究还很缺乏:我们进行了孟德尔随机化研究,以调查欧洲人群中乳腺癌与子宫内膜癌风险之间的因果关系:结果:共有 112 个有效的工具变量(IV)被纳入分析。我们的研究揭示了乳腺癌遗传易感性与子宫内膜癌发病几率增加之间令人信服的因果关系(逆方差加权(IVW)法,几率比(OR)= 1.105, 95 % 置信区间 (CI): 1.025 to 1.181, p = 0.003; 加权中位数法,OR = 1.109, 95 % CI: 1.020 to 1.205, p = 0.015; 加权模式法,OR = 1.101, 95 % CI: 1.013 to 1.195, p = 0.025):据我们所知,该研究首次报告了乳腺癌与子宫内膜癌风险之间的因果关系。通过对异质性和多义性的严格测试,得出了可靠的结果。我们的研究结果表明,乳腺癌对子宫内膜癌风险有因果关系。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
CiteScore
4.60
自引率
3.80%
发文量
898
审稿时长
8.3 weeks
期刊介绍: The European Journal of Obstetrics & Gynecology and Reproductive Biology is the leading general clinical journal covering the continent. It publishes peer reviewed original research articles, as well as a wide range of news, book reviews, biographical, historical and educational articles and a lively correspondence section. Fields covered include obstetrics, prenatal diagnosis, maternal-fetal medicine, perinatology, general gynecology, gynecologic oncology, uro-gynecology, reproductive medicine, infertility, reproductive endocrinology, sexual medicine and reproductive ethics. The European Journal of Obstetrics & Gynecology and Reproductive Biology provides a forum for scientific and clinical professional communication in obstetrics and gynecology throughout Europe and the world.
期刊最新文献
Corrigendum to "Mode of delivery predicts postpartum maternal leukocyte telomere length" [Eur. J. Obstetr. Gynecol. Reprod. Biol. 300 (2024) 224-229]. Corrigendum to “Recombinant-Luteinzing hormone supplementation in women during IVF/ICSI cycles with GnRH-antagonist protocol: A systematic review and meta-analysis” [Eur. J. Obstet. Gynecol. Reprod. Biol. 283 (2023) 43–48] Comparative study on the effects of combined oral contraceptives and dienogest in women with endometriosis‑associated chronic pelvic pain Severe uterine haemorrhagic complications from gestational trophoblastic neoplasia Prediction of perinatal mortality in early-onset fetal growth restriction: A post hoc analysis of the Dutch STRIDER trial to predict perinatal mortality in early-onset fetal growth restriction
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1